RxDoctor Payments Data

Sharon Irvine, DO

Family Medicine · Mansfield, TXNPI 1811915762

Payments from drug & device makers

$388in general payments, 2019–2025

Across 22 payments — averaging $17.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$84
  • Amgen$65
  • Sanofi-aventis U.S. LLC$47
  • Abbott$33
  • Lilly USA, LLC$33
  • GSK$25
  • plus $102 from 6 others

What the payments were for

  • Food & beverage$388100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$388 in reported general payments places this provider in the 45th percentile of 8,760 family medicine providers in Texas.

See all family medicine providers in Texas

Medicare billing

Part B allowed, 2024
$12,730
Medicare patients
40
Services billed
137

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Rosuvastatin Calcium16$114
Lisinopril24$91
Losartan Potassium11$79
Levothyroxine Sodium15$59

Paid to pharmacies, not to this prescriber.

Other family medicine in Mansfield

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →